HIV, Vascular Risk Factors, and Cognition in the Combination Antiretroviral Therapy Era: A Systematic Review and Meta-Analysis

Overview

Journal J Int Neuropsychol Soc

Publisher Cambridge University Press

Specialties Neurology
Psychology

Date 2020 Nov 9

PMID 33161930

Citations 9

Authors

Elissa C McIntosh

Kayla Tureson

Lindsay J Rotblatt

Elyse J Singer

April D Thames

Affiliations

Soon will be listed here.

Abstract

Objectives: Mounting evidence indicates that vascular risk factors (VRFs) are elevated in HIV and play a significant role in the development and persistence of HIV-associated neurocognitive disorder. Given the increased longevity of people living with HIV (PLWH), there is a great need to better elucidate vascular contributions to neurocognitive impairment in HIV. This systematic review and meta-analysis examine relationships between traditional VRFs, cardiovascular disease (CVD), and cognition in PLWH in the combination antiretroviral therapy era.

Methods: For the systematic review, 44 studies met inclusion criteria and included data from 14,376 PLWH and 6,043 HIV-seronegative controls. To better quantify the contribution of VRFs to cognitive impairment in HIV, a robust variance estimation meta-analysis (N = 11 studies) was performed and included data from 2139 PLWH.

Results: In the systematic review, cross-sectional and longitudinal studies supported relationships between VRFs, cognitive dysfunction, and decline, particularly in the domains of attention/processing speed, executive functioning, and fine motor skills. The meta-analysis demonstrated VRFs were associated with increased odds of global neurocognitive impairment (odds ratio [OR ]= 2.059, p = .010), which remained significant after adjustment for clinical HIV variables (p = .017). Analyses of individual VRFs demonstrated type 2 diabetes (p = .004), hyperlipidemia (p = .043), current smoking (p = .037), and previous CVD (p = .0005) were significantly associated with global neurocognitive impairment.

Conclusions: VRFs and CVD are associated with worse cognitive performance and decline, and neurocognitive impairment in PLWH. Future studies are needed to examine these relationships in older adults with HIV, and investigate how race/ethnicity, gender, medical comorbidities, and psychosocial factors contribute to VRF-associated cognitive dysfunction in HIV.

Citing Articles

HIV Stigma is Associated with Two-Year Decline in Cognitive Performance Among People with HIV.

Britton M, Lembo M, Li Y, Porges E, Cook R, Cohen R AIDS Behav. 2024; 29(1):90-100.

PMID: 39397137 PMC: 11747836. DOI: 10.1007/s10461-024-04508-7.

Lack of Association of Vascular Risk Factors with HIV-Associated Neurocognitive Disorders in cART-Treated Adults Aged ≥ 50 Years in Tanzania.

Flack K, Rainey E, Urasa S, Koipapi S, Kalaria R, Howlett W Viruses. 2024; 16(6).

PMID: 38932112 PMC: 11209468. DOI: 10.3390/v16060819.

Self-perceived cognitive fluctuations and their relationship to everyday functioning in older adults with and without HIV disease.

Lorkiewicz S, Webber T, Sober J, Kiselica A, Woods S Clin Neuropsychol. 2024; 38(5):1085-1108.

PMID: 38914007 PMC: 11196870. DOI: 10.1080/13854046.2023.2282728.

Examining biopsychosocial predictors of risk for cognitive impairment among a racially diverse sample of men who have sex with men living with HIV.

Hall C, Okantey B, Meng Z, Sabuncu C, Lane B, Millender E Ther Adv Infect Dis. 2024; 11:20499361241249657.

PMID: 38751756 PMC: 11095190. DOI: 10.1177/20499361241249657.

Implications of vascular depression for successful cognitive aging in HIV Disease.

Mustafa A, Beltran-Najera I, Evans D, Bartlett A, Dotson V, Woods S J Neurovirol. 2024; 30(2):1-11.

PMID: 38546936 DOI: 10.1007/s13365-024-01201-2.

References

Fabbiani M, Ciccarelli N, Tana M, Farina S, Baldonero E, Di Cristo V . Cardiovascular risk factors and carotid intima-media thickness are associated with lower cognitive performance in HIV-infected patients. HIV Med. 2012; 14(3):136-44. DOI: 10.1111/j.1468-1293.2012.01044.x. View

Taki Y, Goto R, Evans A, Zijdenbos A, Neelin P, Lerch J . Voxel-based morphometry of human brain with age and cerebrovascular risk factors. Neurobiol Aging. 2004; 25(4):455-63. DOI: 10.1016/j.neurobiolaging.2003.09.002. View

Patel S, Thames A, Arbid N, Panos S, Castellon S, Hinkin C . The aggregate effects of multiple comorbid risk factors on cognition among HIV-infected individuals. J Clin Exp Neuropsychol. 2013; 35(4):421-34. PMC: 3641576. DOI: 10.1080/13803395.2013.783000. View

Borenstein M, Hedges L, Higgins J, Rothstein H . A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods. 2015; 1(2):97-111. DOI: 10.1002/jrsm.12. View

Durazzo T, Meyerhoff D, Nixon S . A comprehensive assessment of neurocognition in middle-aged chronic cigarette smokers. Drug Alcohol Depend. 2011; 122(1-2):105-11. PMC: 3258460. DOI: 10.1016/j.drugalcdep.2011.09.019. View

Yaldizli O, Kastrup O, Obermann M, Esser S, Wilhelm H, Ley C . Carotid intima-media thickness in HIV-infected individuals: relationship of premature atherosclerosis to neuropsychological deficits?. Eur Neurol. 2006; 55(3):166-71. DOI: 10.1159/000093576. View

Montoya J, Iudicello J, Fazeli P, Hong S, Potter M, Ellis R . Elevated Markers of Vascular Remodeling and Arterial Stiffness Are Associated With Neurocognitive Function in Older HIV+ Adults on Suppressive Antiretroviral Therapy. J Acquir Immune Defic Syndr. 2016; 74(2):134-141. PMC: 5233588. DOI: 10.1097/QAI.0000000000001230. View

Jefferson A, Hohman T, Liu D, Haj-Hassan S, Gifford K, Benson E . Adverse vascular risk is related to cognitive decline in older adults. J Alzheimers Dis. 2014; 44(4):1361-73. PMC: 4336578. DOI: 10.3233/JAD-141812. View

Yang Y, Yao W, Yeh T, Lee I, Chen P, Lu R . Decreased dopamine transporter availability in male smokers -- a dual isotope SPECT study. Prog Neuropsychopharmacol Biol Psychiatry. 2007; 32(1):274-9. DOI: 10.1016/j.pnpbp.2007.08.018. View

10.

McCutchan J, Marquie-Beck J, Fitzsimons C, Letendre S, Ellis R, Heaton R . Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder. Neurology. 2012; 78(7):485-92. PMC: 3280051. DOI: 10.1212/WNL.0b013e3182478d64. View

11.

Ciccarelli N, Grima P, Fabbiani M, Baldonero E, Borghetti A, Milanini B . Baseline CD4(+) T-cell count and cardiovascular risk factors predict the evolution of cognitive performance during 2-year follow-up in HIV-infected patients. Antivir Ther. 2014; 20(4):433-40. DOI: 10.3851/IMP2925. View

12.

Saloner R, Campbell L, Serrano V, Montoya J, Pasipanodya E, Paolillo E . Neurocognitive SuperAging in Older Adults Living With HIV: Demographic, Neuromedical and Everyday Functioning Correlates. J Int Neuropsychol Soc. 2019; 25(5):507-519. PMC: 6705613. DOI: 10.1017/S1355617719000018. View

13.

van den Berg E, Kloppenborg R, Kessels R, Kappelle L, Biessels G . Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity: A systematic comparison of their impact on cognition. Biochim Biophys Acta. 2008; 1792(5):470-81. DOI: 10.1016/j.bbadis.2008.09.004. View

14.

Hsue P, Hunt P, Schnell A, Kalapus S, Hoh R, Ganz P . Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis. AIDS. 2009; 23(9):1059-67. PMC: 2691772. DOI: 10.1097/QAD.0b013e32832b514b. View

15.

Calza L, Manfredi R, Chiodo F . Dyslipidaemia associated with antiretroviral therapy in HIV-infected patients. J Antimicrob Chemother. 2003; 53(1):10-4. DOI: 10.1093/jac/dkh013. View

16.

Valcour V, Sacktor N, Paul R, Watters M, Selnes O, Shiramizu B . Insulin resistance is associated with cognition among HIV-1-infected patients: the Hawaii Aging With HIV cohort. J Acquir Immune Defic Syndr. 2006; 43(4):405-10. DOI: 10.1097/01.qai.0000243119.67529.f5. View

17.

Womack J, Chang C, So-Armah K, Alcorn C, Baker J, Brown S . HIV infection and cardiovascular disease in women. J Am Heart Assoc. 2014; 3(5):e001035. PMC: 4323817. DOI: 10.1161/JAHA.114.001035. View

18.

Valcour V, Rubin L, Tien P, Anastos K, Young M, Mack W . Human immunodeficiency virus (HIV) modulates the associations between insulin resistance and cognition in the current combination antiretroviral therapy (cART) era: a study of the Women's Interagency HIV Study (WIHS). J Neurovirol. 2015; 21(4):415-21. PMC: 4511712. DOI: 10.1007/s13365-015-0330-6. View

19.

Sanford R, Strain J, Dadar M, Maranzano J, Bonnet A, Mayo N . HIV infection and cerebral small vessel disease are independently associated with brain atrophy and cognitive impairment. AIDS. 2019; 33(7):1197-1205. PMC: 7924885. DOI: 10.1097/QAD.0000000000002193. View

20.

Triant V . Cardiovascular disease and HIV infection. Curr HIV/AIDS Rep. 2013; 10(3):199-206. PMC: 3964878. DOI: 10.1007/s11904-013-0168-6. View